Anticoagulation, though, significantly reduces the risk of thromboembolism in APS as shown by multiple studies.49 50 Martinez-Berriotxoa et al51 suggested that transiently positive aCL antibodies do not confer thrombotic risk. The gene discussed is ACLY; the disease is autoimmune polyendocrinopathy.